These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16239581)

  • 21. Mice immunized by primary vaginal Candida albicans infection develop acquired vaginal mucosal immunity.
    Fidel PL; Lynch ME; Conaway DH; Tait L; Sobel JD
    Infect Immun; 1995 Feb; 63(2):547-53. PubMed ID: 7822020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Local anticandidal immune responses in a rat model of vaginal infection by and protection against Candida albicans.
    de Bernardis F; Santoni G; Boccanera M; Spreghini E; Adriani D; Morelli L; Cassone A
    Infect Immun; 2000 Jun; 68(6):3297-304. PubMed ID: 10816477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human vaginal epithelial cells augment autophagy marker genes in response to Candida albicans infection.
    Shroff A; Sequeira R; Reddy KVR
    Am J Reprod Immunol; 2017 Apr; 77(4):. PubMed ID: 28185353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct protective host defenses against oral and vaginal candidiasis.
    Fidel PL
    Med Mycol; 2002 Aug; 40(4):359-75. PubMed ID: 12230215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-Candida activity of beneficial vaginal lactobacilli in in vitro assays and in a murine experimental model.
    De Gregorio PR; Silva JA; Marchesi A; Nader-Macías MEF
    FEMS Yeast Res; 2019 Mar; 19(2):. PubMed ID: 30689833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent vulvovaginal candidiasis: vaginal epithelial cell susceptibility to Candida albicans adherence.
    Trumbore DJ; Sobel JD
    Obstet Gynecol; 1986 Jun; 67(6):810-2. PubMed ID: 3517722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The protective immune response against vaginal candidiasis: lessons learned from clinical studies and animal models.
    Fidel PL
    Int Rev Immunol; 2002; 21(6):515-48. PubMed ID: 12650240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection against rat vaginal candidiasis by adoptive transfer of vaginal B lymphocytes.
    De Bernardis F; Santoni G; Boccanera M; Lucciarini R; Arancia S; Sandini S; Amantini C; Cassone A
    FEMS Yeast Res; 2010 Jun; 10(4):432-40. PubMed ID: 20402794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study on the relationship between vaginal and intestinal candida in patients with vulvovaginal candidiasis].
    Lin XL; Li Z; Zuo XL
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jul; 46(7):496-500. PubMed ID: 22041440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lactobacillus plantarum P17630 for preventing Candida vaginitis recurrence: a retrospective comparative study.
    De Seta F; Parazzini F; De Leo R; Banco R; Maso GP; De Santo D; Sartore A; Stabile G; Inglese S; Tonon M; Restaino S
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():136-9. PubMed ID: 25305660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between recurrent vulvovaginal candidosis and immune mediators in vaginal fluid.
    Weissenbacher TM; Witkin SS; Gingelmaier A; Scholz C; Friese K; Mylonas I
    Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):59-63. PubMed ID: 19261373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The in vitro activity of vaginal Lactobacillus with probiotic properties against Candida.
    Strus M; Kucharska A; Kukla G; Brzychczy-Włoch M; Maresz K; Heczko PB
    Infect Dis Obstet Gynecol; 2005 Jun; 13(2):69-75. PubMed ID: 16011996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human natural yeast killer toxin-like candidacidal antibodies.
    Polonelli L; De Bernadis F; Conti S; Boccanera M; Magliani W; Gerloni M; Cantelli C; Cassone A
    J Immunol; 1996 Mar; 156(5):1880-5. PubMed ID: 8596040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lactobacillus helveticus HY7801 ameliorates vulvovaginal candidiasis in mice by inhibiting fungal growth and NF-κB activation.
    Joo HM; Kim KA; Myoung KS; Ahn YT; Lee JH; Huh CS; Han MJ; Kim DH
    Int Immunopharmacol; 2012 Sep; 14(1):39-46. PubMed ID: 22735758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of systemic cell-mediated immunity on vaginal candidiasis in mice resistant and susceptible to Candida albicans infections.
    Fidel PL; Cutright JL; Sobel JD
    Infect Immun; 1995 Oct; 63(10):4191-4. PubMed ID: 7558342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunotherapeutic approaches to enhance protective immunity against Candida vaginitis.
    Wozniak KL; Palmer G; Kutner R; Fidel PL
    Med Mycol; 2005 Nov; 43(7):589-601. PubMed ID: 16396244
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Niu XX; Li T; Zhang X; Wang SX; Liu ZH
    Chin Med J (Engl); 2017 Feb; 130(3):273-279. PubMed ID: 28139509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic and mucosal immunization with Candida albicans hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis.
    Raska M; Belakova J; Horynova M; Krupka M; Novotny J; Sebestova M; Weigl E
    Med Mycol; 2008 Aug; 46(5):411-20. PubMed ID: 18608941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine.
    Sandini S; La Valle R; Deaglio S; Malavasi F; Cassone A; De Bernardis F
    FEMS Immunol Med Microbiol; 2011 Jul; 62(2):215-24. PubMed ID: 21535228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent vulvovaginal candidiasis: why does it occur?
    Rodgers CA; Beardall AJ
    Int J STD AIDS; 1999 Jul; 10(7):435-9; quiz 440-1. PubMed ID: 10454177
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.